(Q62595296)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19011664%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

HLA-E upregulation on IFN-gamma-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19011664%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19011664%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

S Nguyen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19011664%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

N Dhedin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19011664%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

M Kuentz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19011664%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J P Vernant

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19011664%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

P Debre

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19011664%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

V Vieillard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19011664%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

17 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19011664%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19011664%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19011664%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19011664%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

693-699

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19011664%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2008.380

17 January 2020

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

Positive and negative regulation of Natural Killer cells: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

NK cell recognition of non-classical HLA class I molecules

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

HLA class I recognition by killer cell Ig-like receptors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

Human natural killer cell development

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

The biology of human natural killer-cell subsets

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

Involvement of mature donor T cells in the NK cell reconstitution after haploidentical hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

Follow the leader: NK cell receptors for classical and nonclassical MHC class I.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

Interferon-gamma induction of the human leukocyte antigen-E gene is mediated through binding of a complex containing STAT1alpha to a distinct interferon-gamma-responsive element

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

GATA-3 is an important transcription factor for regulating human NKG2A gene expression

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

Natural killer cell developmental pathways: a question of balance.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.380

7 January 2021